Mahmoud R Jaafari Selected Research

Pharmaceutical Preparations

1/2021	Anti-Tumor Efficacy of Pyrvinium Pamoate Nanoliposomes in an Experimental Model of Melanoma.
1/2020	Evaluation of the Anti-Tumor Activity of Niclosamide Nanoliposomes Against Colon Carcinoma.
1/2019	Nanoliposomal Encapsulation Enhances In Vivo Anti-Tumor Activity of Niclosamide against Melanoma.
1/2016	Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mahmoud R Jaafari Research Topics

Disease

13	Neoplasms (Cancer) 01/2021 - 10/2008
8	Leishmaniasis 01/2017 - 08/2007
4	Atherosclerosis 01/2022 - 10/2018
3	Melanoma (Melanoma, Malignant) 01/2021 - 01/2016
3	Carcinoma (Carcinomatosis) 01/2020 - 04/2013
3	Dehydration (Water Stress) 05/2009 - 08/2007
2	Dyslipidemias (Dyslipidemia) 01/2022 - 10/2018
2	Inflammation (Inflammations) 07/2021 - 01/2017
2	Infections 06/2009 - 08/2007
1	Atherosclerotic Plaque (Atheroma) 10/2021
1	Hypercholesterolemia 10/2021
1	Enterobiasis 01/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020
1	Osteoarthritis 01/2020
1	Knee Osteoarthritis 01/2020
1	Pain (Aches) 01/2020
1	Multiple Myeloma 01/2020
1	Parasitic Diseases (Parasitic Disease) 01/2019
1	Cutaneous Leishmaniasis 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Endophthalmitis (Ophthalmia) 05/2009
1	Retinal Detachment (Retinal Detachments) 05/2009
1	Vitreous Hemorrhage 05/2009
1	Cataract (Cataracts) 05/2009

Drug/Important Bio-Agent (IBA)

15	Liposomes (Liposome)IBA 01/2022 - 08/2007
4	VaccinesIBA 07/2021 - 04/2008
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
4	CPG-oligonucleotideIBA 10/2011 - 08/2007
3	AntigensIBA 12/2012 - 08/2007
2	AntibodiesIBA 07/2021 - 02/2020
2	Peptides (Polypeptides)IBA 02/2020 - 01/2018
2	Bortezomib (Velcade)FDA Link 01/2020 - 01/2020
2	Proteasome InhibitorsIBA 01/2020 - 01/2020
2	Niclosamide FDA Link 01/2020 - 01/2019
2	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 10/2008
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2019 - 10/2008
2	Phospholipids (Phosphatides)FDA LinkGeneric 10/2018 - 11/2009
1	Dimyristoylphosphatidylcholine (DMPC)IBA 01/2022
1	dimyristoylphosphatidylglycerol (DMPG)IBA 01/2022
1	distearoyl phosphatidylglycerol (DSPG)IBA 01/2022
1	LipidsIBA 10/2021
1	PhosphatidylserinesIBA 10/2021
1	aluminum sulfate (alum)IBA 07/2021
1	Therapeutic UsesIBA 07/2021
1	pyrvinium (Vankin)FDA Link 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Nanoparticle Drug Delivery SystemIBA 01/2020
1	CurcuminIBA 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020
1	Scarlet Red (Sudan IV)IBA 10/2018
1	CollagenIBA 10/2018
1	Lipid Bilayers (Lipid Bilayer)IBA 10/2018
1	LDL Receptors (LDL Receptor)IBA 10/2018
1	CholesterolIBA 10/2018
1	LigandsIBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	liposomal amphotericin B FDA Link 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2017
1	1,2- distigmasterylhemisuccinoyl- glycero- 3- phosphocholineIBA 01/2017
1	ChemokinesIBA 01/2016
1	pigment epithelium-derived factorIBA 01/2016
1	Cytosine DeaminaseIBA 01/2016
1	InterferonsIBA 01/2016
1	Cisplatin (Platino)FDA LinkGeneric 12/2015
1	Polyethylene (Polythene)IBA 04/2013
1	BuffersIBA 04/2013
1	crocinIBA 04/2013
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 12/2012
1	AlginatesIBA 10/2011
1	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 06/2009
1	Bevacizumab (Avastin)FDA Link 05/2009
1	OligodeoxyribonucleotidesIBA 04/2008
1	Leishmania major stress-inducible protein 1IBA 04/2008

Therapy/Procedure

4	Therapeutics 02/2020 - 01/2016
3	Fluid Therapy (Oral Rehydration Therapy) 05/2009 - 08/2007
1	Immunotherapy 02/2020
1	Drug Therapy (Chemotherapy) 02/2020
1	Microspheres (Microsphere) 10/2011
1	Nanospheres 05/2011
1	Injections 05/2009
1	Intravitreal Injections 05/2009